The DEA Is About to Schedule 'Gas Station Heroin.' Kratom Itself Gets to Stay Legal.
Daily Pulse: DEA moved to place concentrated 7-OH extracts in Schedule I while leaving the kratom leaf they're derived from alone — a narrower line than the convenience-store shelf suggests.
This week the DEA filed notices of intent to place 7-hydroxymitragynine — 7-OH — and three synthetic derivatives into Schedule I, the same category as heroin. HHS Secretary Robert F. Kennedy Jr. called them “dangerous opioids that fuel addiction and put American lives at risk.” DEA Administrator Terrance Cole framed it as giving “law enforcement and public health partners the tools needed to address this emerging threat.”
The threat is real. The fix is more precise than the headline lets on, and precision is the whole reason it might actually work.
The proposed threshold is 0.050 percent 7-OH by dry weight in botanical products, or 0.050 percent (or 1.00 mg) in processed extracts, pills, and edibles. That line matters: it targets concentrated, synthetically boosted 7-OH products — the kind Arizona physicians have been calling “gas station heroin” for months, sold at convenience stores as a legal opioid-adjacent high — without criminalizing traditional kratom leaf, which contains 7-OH only in trace natural amounts. Trade coverage aimed at the retailers who stock these products confirms the same read: this is a strike on the synthetic extract market, not a ban on the plant millions of Americans already use, often to manage chronic pain or taper off opioids themselves.
That distinction is worth defending loudly, because past scheduling actions in this space haven’t always drawn it. Sweeping an entire plant into Schedule I because a subset of manufacturers concentrated its most potent alkaloid into something closer to a synthetic opioid punishes exactly the people using kratom leaf as a lower-risk substitute — often people actively trying to get off something stronger. A 30-day comment period on the threshold itself is open now, which means the line between “leaf” and “gas station heroin” isn’t finalized. If you work in harm reduction, treatment, or primary care in Arizona, that comment period is the actual lever, not the headline.
Arizona already has its own answer on the books: the state’s Kratom Consumer Protection Act caps legal 7-OH concentration under 2 percent, a narrower guardrail than what DEA is now proposing nationally. The federal government is finally catching up to a distinction Arizona lawmakers made years ago. Get the threshold right, and the products actually killing people in gas station parking lots disappear without touching the leaf someone’s using to stay off fentanyl.
Sources Cited
- 01.A
- 02.CDEA to Temporarily Ban Synthetic KratomNACS (National Association of Convenience Stores)
- 03.B
Filed Under
policyharm-reductionKratomArizona
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Insurers Got a Year and a Half of Breathing Room on the Law That's Supposed to Cover Your Treatment
The Departments of Labor, HHS, and Treasury paused enforcement of the 2024 Mental Health Parity Final Rule while litigation plays out — leaving insurers more room on prior authorization and visit limits for addiction treatment, with no enforcement deadline in sight.
Policy & FundingKratom's Civil War Just Reached a Cabinet Secretary's Investment Portfolio
The DEA placed synthetic 7-OH kratom extracts in Schedule I this week. A Senate inquiry into a cabinet secretary's stake in a rival kratom brand shows how much money is riding on where that line gets drawn — and who it leaves without a legal option.
Policy & FundingThe Global Stimulant Boom Is Hitting a Treatment System Built for Opioids
UNODC's 2026 World Drug Report found cocaine production at an all-time high and meth going industrial. The US treatment system, built around opioids, has no medication equivalent for stimulants — and hobbles the one behavioral treatment that works.